Novo Nordisk debuts Wegovy weight-loss pill in the U.S.
FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo Nordisk.
Weight Loss
Details on FDA-approved GLP-1 pill for weight loss
The FDA has approved the first GLP-1 pill for weight loss and it's expected in pharmacies in the coming weeks. Dr. Holly Lofton, director of the Medical Weight Management Program at NYU Langone, joins CBS News to discuss.
FDA approves Wegovy pill for weight loss
The Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy.
FDA approves Wegovy pill for weight loss
The FDA has approved the pill version of the weight loss drug Wegovy, the first oral medication of its kind. The new pills are expected to be available in a few weeks. Chief medical correspondent Dr. Jon LaPook has more.
How GLP-1 drugs are shifting consumer habits
The rise in the use of GLP-1 weight-loss drugs across the U.S. is shifting not only scales, but also how Americans are spending their time and money. Washington Post retail reporter Jaclyn Peiser explains.
GLP-1 drugs and muscle loss: What to know
A recent KFF poll revealed that one in eight adults in the U.S. is currently taking a GLP-1 weight loss drug. As more people start using them, some are talking about the unexpected side effects, including muscle loss and weakness. Senior Vox correspondent Dylan Scott joins CBS News to share what patients told him.
Could pets be next for weight loss drugs? Here's what to know about a study.
A clinical study into weight loss drugs for pets just launched, with results from the trial expected by next summer.
Can weight loss drugs be used for pets?
Experts say roughly six in 10 cats in the U.S. are carrying too much weight. A new clinical trial, "MEOW-1," could change that, testing to see if GLP-1 weight loss drugs can be used on pets. Ash-har Quraishi reports.
Company studying GLP-1s for cats
Weight loss drugs for Americans have skyrocketed to success. Now, the GLP-1 frenzy could be heading to a new frontier: your pets. A San Francisco biopharmaceutical company says it is conducting a pilot study on a GLP-1 drug for cats with obesity. Okava CEO Michael Klotsman joins CBS News to discuss.
Details on lower weight loss drugs prices
President Trump announced a deal on Thursday that will lower the cost of some weight loss drugs for certain eligible Americans. CBS News medical contributor Dr. Celine Gounder explains the details of the deal and how much Americans can expect to pay.
Trump announces deal to lower weight loss drug prices in some cases
The deal, with Eli Lilly and Novo Nordisk, is expected to lower the price of obesity drugs to between $149 and $350 per month in some cases, officials said.
Doctor on lowering weight loss drug costs
President Trump announced a deal with Eli Lilly and Novo Nordisk on Thursday to lower the cost of their weight loss drugs for some Americans. Dr. Holly Lofton, NYU Langone Medical's weight management program director, joins "The Daily Report" to discuss.
Novo Nordisk CEO on Trump drug prices deal
President Trump on Thursday unveiled agreements slashing the prices of two pharmaceutical companies' weight loss drugs. Novo Nordisk CEO Mike Doustdar joins "The Takeout" to unpack the cost-cutting effort.
Deal could lower cost of weight loss drugs
Some people on weight loss drugs may be able to get them at a much lower cost next year after President Trump announced a new deal on Thursday with the drug makers of certain GLP-1s. CBS News senior White House and political correspondent Ed O'Keefe reports.
Doctor discusses weight-loss drug deals
The Trump administration announced Thursday a deal to lower the price of weight loss drugs for some Americans. Dr. Bayo Curry-Winchell, founder of Beyond Clinical Walls, joins CBS News 24/7 to discuss the news.
Trump on slashing weight loss drug prices
President Trump announced Thursday a deal with Eli Lilly and Novo Nordisk to reduce prices for popular weight loss drugs for some Americans. CBS News' Aaron Navarro has more.
Trump announces deal to lower drug prices
President Trump announced a deal to lower the price of weight loss drugs for some Americans. CBS News' Jennifer Jacobs has more.
Obesity rate is declining as more Americans use weight loss drugs, survey finds
As more Americans turn to weight loss drugs, the U.S. adult obesity rate is declining, according to new survey data from Gallup.
Costco to sell weight loss drugs
Shoppers can now find Ozempic and Wegovy at Costco. It says it is partnering with drugmaker Novo Nordisk to offer the drugs at a steep discount for members with a prescription. CBS News reporter Andres Gutierrez has more.
Is microdosing weight loss drugs safe?
There is a growing trend of microdosing with Ozempic and other popular weight loss drugs. People are taking much smaller amounts, or splitting up doses, to save money or cut down on side effects. CBS News medical contributor Dr. Celine Gounder addresses safety concerns and if the strategy works.
Drugs with weight loss side effects in demand
Medications that have a side effect of weight loss have seen a recent influx of popularity. Some manufacturers say they're having difficulty keeping up with increased demand as the medications become more normalized as a way to lose weight even though that's not the primary purpose for them. Dr. Lisa Palmer, a psychotherapist and founder of the Renew Center of Florida, joined CBS News to talk about the risks.
Serena Williams speaks on GLP-1s
Serena Williams made headlines this week, not for her tennis court achievements, but for her health challenges since giving birth to her two children. She revealed she lost about 30 pounds by using a GLP-1 medication, such as Wegovy and Zepbound, through the telehealth company Ro. She serves as a paid spokesperson. CBS News' Dr. Céline Gounder has more.
Serena Williams reveals she's using weight loss drugs and addresses stigma
Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using GLP-1s.
Doctor on ultra-processed foods
Some new studies and data out this week are giving fresh insight into ultra-processed foods. A major clinical trial conducted in the United Kingdom found that diets containing ultra-processed foods are associated with increased cravings and higher calorie consumption. CBS News medical contributor Dr. Celine Gounder has expert takeaways.
Eli Lilly weight loss pill shows promise in latest clinical trial
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.
Trump says he'll start paying for ads after pushback over taxpayer funding
Jim Bakker, who co-founded "The PTL Club" but fell into disgrace, dies at 86
Trump suggests letting Iran "take out" LA, San Diego during rally
Live
Battle with Iran-backed Houthis in Yemen tempers news on oil flow
Ex-"American Idol" contestant Caleb Flynn gets life sentence
Chicago-bound flight drops 27,000 feet, returns to London
Alleged Chinese agent makes federal court appearance
Only On CBS
Takeaways from Alito's CBS News interview
